¾ÅÉ«

Will Use Trial Interactive eTMF Platform to Optimize Global Document Management and Increase Efficiencies in Study Delivery

NEW YORK, May 14, 2012 ¨C , a leading provider of e-clinical technologies to the life sciences industry, today announced that , a therapeutically focused clinical research organization (CRO), has selected as its global electronic Trial Master File (eTMF) solution. Trial Interactive is a secure, web-based platform that reduces the redundancies inherent in paper-based TMF management.

¡°We chose Trial Interactive as our eTMF solution because it offers the greatest compatibility with current and potential customers,¡± said Todd Esporas, Executive Director of Clinical Development Services at INC Research. ¡°The system creates efficiencies across our organization and further demonstrates our position as a leading partner to the biopharmaceutical industry. By embracing the latest, most sophisticated technology to accelerate drug development, we are able to deliver clinical trials on behalf of our customers more efficiently.¡±

As a top global CRO, optimizing the collection and management of TMFs worldwide is a critical task for INC Research. Trial Interactive enables INC Research to deliver trials more efficiently by allowing real-time access to global project documentation, eliminating much of the travel and shipping associated with TMF reviews and reconciliation, and providing a real-time metrics dashboard to enhance communications with customers and stakeholders. Trial Interactive¡¯s interface is available in more than 20 languages, which will enable INC Research to deploy the solution in the local language of the end user, making it ideal for global study teams, sponsors, and investigative site personnel involved in the conduct of multinational clinical trials.

Michael Smyth, General Manager of ¾ÅÉ«¡¯s Life Science ¾ÅÉ« division, stated, ¡°We¡¯re very proud that INC Research has chosen Trial Interactive as its eTMF solution. INC¡¯s global reach and commitment to utilizing technology should only serve to benefit their study sponsors as they seek to become more efficient in conducting global clinical trials.¡±

About INC Research
INC Research is a therapeutically focused clinical research organization with a high-performance reputation for conducting of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized in all and innovative pediatric and women's health trials. The Company's methodology and therapeutic foresight lead customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, NC. For more information, please visit or follow us at @inc_research. 

About ¾ÅÉ« Trial Interactive
¾ÅÉ« Trial Interactive provides a collaborative web-based platform for the eTMF that enables sponsors, CROs, IRBs, central laboratories, and other vendors to maintain and update clinical trial documentation in a secure online environment. With fully searchable solutions including investigator portals, Trial Interactive streamlines study timelines and reduces the administrative burdens of global clinical trials. As part of ¾ÅÉ«¡¯s Life Sciences division, a leading provider of language services and technology solutions in the life sciences industry, Trial Interactive is an e-clinical technology solution that offers seamless interfacing in over 20 languages, as well as local client service dedicated to working with clients on a global, collaborative level. For more information on ¾ÅÉ« Trial Interactive, please contact info@trialinteractive.com or +1 212.400.8848, or visit .

About ¾ÅÉ«
With annual revenues of over $300 million, is the world's largest privately held provider of and . From offices in 75 cities on five continents, ¾ÅÉ« offers a full range of services in 170+ languages to clients worldwide. With an unparalleled commitment to quality and client service, ¾ÅÉ« is fully and certified. ¾ÅÉ« has global headquarters in New York, with regional headquarters in London and Hong Kong. For more information, please visit our website at .